Assessment of Tissue-Specific Glucose Uptake: Teaching an Old 2-DOG New Tricks

Max C Petersen,Michael J Jurczak,Max C. Petersen,Michael J. Jurczak
DOI: https://doi.org/10.2337/db23-0816
IF: 7.7
2024-02-22
Diabetes
Abstract:A major function of insulin in skeletal muscle, heart, and white and brown adipose tissue is to stimulate cellular glucose uptake (1). Tissue-specific measurements of insulin-stimulated glucose uptake are useful for dissecting the mechanisms underlying abnormalities detected by tests of whole-body glucose homeostasis, such as the glucose or insulin tolerance test. Several methods using isotope-labeled, nonmetabolizable glucose tracers are available for assessing tissue-specific glucose uptake in vivo, including [ 18 F]fluorodeoxyglucose (FDG) positron emission tomography (2) and bolus injection of [ 14 C]2-deoxyglucose (2-DOG) during a hyperinsulinemic-euglycemic clamp (3). These tracers behave like glucose and enter the cell by facilitated diffusion via GLUT transporters. Following uptake, 2-DOG is phosphorylated by hexokinase but cannot be metabolized further by the glycolytic machinery. The phosphorylated glucose tracer is therefore trapped in cell types that do not express glucose-6-phosphatase, enabling measurement of tissue-specific glucose uptake. However, these techniques require specialized equipment, demand procedural expertise, and are generally low throughput (4). They also measure glucose uptake under one condition (e.g., basal or insulin stimulated), limiting data interpretation.
endocrinology & metabolism
What problem does this paper attempt to address?